Page 9 - Drugs

Pharmaceutical companies prepare to comply with ethical marketing code

Companies must commit that they comply with a code against unethical marketing of drugs

Jubilant Pharmova Q4 results: Consolidated net loss narrows to Rs 5.86 cr

Revenue from segments that make copycat drugs and medicines used for allergy immunotherapy rose 0.8% and 14%, respectively, during the quarter

GSK's trial drug Depemokimab shows reduction in severe asthma attacks

This form of asthma is characterised by high levels of eosinophils, which is a type of white blood cell.

GSK faces lawsuit from lab that found probable carcinogen in Zantac

Big drugmakers already face some 80,000 state suits from users of the drug who say their cancers were caused by Zantac contaminated with NDMA, the dangerous chemical Valisure discovered

Indian pharma firms supplied 47% of all generic prescriptions in US in 2022

Indian pharmaceutical companies also accounted for a lower but important share of biosimilar production, manufacturing 15 per cent of biosimilar volume used by US patients in 2022

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs

Prices of essential drugs such as dapagliflozin metformin hydrochloride, used for lowering blood glucose levels by decreasing glucose production in the liver, have been fixed at Rs 16 per tablet

Cipla, Glenmark recall drugs from US over manufacturing issues: USFDA

Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), a New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. The medication, produced at the company's Indore SEZ plant, is used to help control the symptoms of lung diseases, such as asthma, chronic bronchitis and emphysema. Cipla USA is recalling the affected lot due to "short fill". There were complaints of less fill volume in respule and few drops of liquid observed in the intact pouch, USFDA said. Cipla initiated the Class II recall in the US market on March 26 this year. USFDA also said that Glenmark Pharma is recalling 3,264 bottles of Diltiazem Hydrochloride extended-release capsules indicated for high blood pressure. The US-based arm of the company -- Glenmark ...

Glenmark Pharma receives USFDA nod for generic anti-inflammatory drug

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to sell a generic version of anti-inflammatory drug in the American market. The company has received approval from the US Food and Drug Administration (USFDA) for Acetaminophen and Ibuprofen tablets (250 mg/125 mg), the Mumbai-based drug maker said in a statement. The company's product is the generic version of Haleon US Holdings, LLC's Advil 2 Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC), it added. Glenmark Therapeutics Inc, USA will distribute the drug in the US market, the drug maker said. According to Nielsen syndicated data for the latest 52 weeks period ending March 23, 2024, the Advil Dual Action with Acetaminophen Tablets, 250 mg/125 mg achieved annual sales of around USD 84.1 million. Glenmark said its current portfolio consists of 195 products authorised for distribution in the US marketplace and 52 abbreviated new drug applications (ANDAs) pending approval with

13 held with mephedrone worth Rs 230 cr, after raids in Gujarat, Rajasthan

The Gujarat Anti Terrorist Squad and Narcotics Control Bureau jointly raided four units in the state and neighbouring Rajasthan and nabbed 13 persons allegedly with mephedrone worth Rs 230 crore, an official said on Saturday. The raids were carried out on Friday after the ATS received a tip off that Ahmedabad-resident Manoharlal Enani and Kuldeepsinh Rajpurohit of Rajasthan had set up mephedrone manufacturing units. A watch was kept on the movements of Enani and Rajpurohit as well as their accomplices, following which raids were carried out on units in Sirohi and Jodhpur in Rajasthan and Piplaj village in Gandhinagar and Bhaktinagar industrial area of Amreli district in Gujarat, an ATS release informed. "The ATS recovered 22.028 kilograms of mephedrone and 124 kilograms of liquid mephedrone, collectively worth Rs 230 crore. Rajpurohit was nabbed during the raid at Gandhinagar and Enani was held from Sirohi," it said. As per the probe, Enani was in jail for seven years after he was

AstraZeneca trounces Q1 estimates as resilient demand fuels growth

AstraZeneca stuck by its forecast of total revenue and core earnings per share increasing by percentages in the low double-digits to low-teens in 2024

Govt expands committee for drugs, medical devices pricing reforms

According to an industry source, the committee will also look at ways to design a price moderation framework for medical devices while providing incentives to the medtech industry to minimize imports

Breaking Bad: What's behind so many meth lab busts in Greater Noida?

Greater Noida is now a surprising hotspot for drug busts involving foreigners running meth labs. In a recent raid, 26.67 kg of drugs valued at Rs 100 crore were seized

Powered by iPhone exports, electronics become India's fifth largest export

Apple's iPhone exports alone now constitute 35% India's entire electronics export goods basket

Glenmark Pharma recalls 6,528 bottles of blood pressure drug in US

Glenmark Pharmaceuticals is recalling 6,528 bottles of a medication used to treat high blood pressure in the American market due to failed dissolution specifications, the US health regulator said. The US-based arm of the Mumbai-headquartered drug firm is recalling the affected lot of Diltiazem Hydrochloride extended-release capsules, the US Food and Drug Administration said in its latest Enforcement Report. The affected lot has been produced in India and is being recalled by New Jersey-based Glenmark Pharmaceuticals Inc for "failed dissolution specifications", the USFDA said. "Out of Specification (OOS) was reported in a test of dissolution at the 12th month time point in long-term stability study," it noted. Glenmark initiated Class II recall of the drug across the US on March 26 this year. As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences

5 dead, over 100 hospitalised from recalled Japanese health supplements

Kobayashi Pharmaceutical Co. came under fire for not going public quickly with problems known internally as early as January

Drugs planted to frame lawyer: Former IPS officer Bhatt gets 20 yrs in jail

A sessions court in Palanpur in Gujarat's Banaskantha district on Thursday sentenced former IPS officer Sanjiv Bhatt to 20 years in jail in a 1996 case involving planting of drugs to frame a lawyer. Bhatt, who is already behind bars in a custodial death case, was held guilty of falsely implicating a Rajasthan-based lawyer by claiming, in 1996, that police had seized drugs from a hotel room in Palanpur where the lawyer was staying. Bhatt, who was sacked from the force in 2015, was serving as the superintendent of police of Banaskantha district at the time. Additional District and Sessions Judge J N Thakkar convicted Bhatt on Wednesday under relevant sections of Narcotics Drugs and Psychotropic Substances (NDPS) Act and Indian Penal Code. The quantum of punishment was announced on Thursday.

YouTuber Elvish Yadav gets bail in drugs case, to be taken to Gurugram jail

A Gautam Buddh Nagar court granted bail to controversial YouTuber Siddharth Yadav alias Elvish Yadav in a drugs case on Friday, six days after he was lodged in a jail here, his lawyers said. The jail authorities said they have received Yadav's release order but he would be handed over on Saturday to the custody of a court in Haryana's Gurugram, where he is to be produced in an assault case involving content creator Sagar Thakur alias Maxtern. The hearing in the Gurguram court is scheduled for March 27. Yadav was arrested on March 17 by the Noida Police in connection with its probe into suspected use of snake venom as a recreational drug in parties he hosted. Additional Chief Judicial Magistrate Jaihind Kumar Singh also granted bail to two of the YouTuber's associates -- Ishwar and Vinay Yadav -- who were arrested on Thursday, advocate Prashant Rathi said. "The court has granted bail to Yadav, who will have to furnish two bail bonds of Rs 50,000 each," the lawyer who represented th

Noida police arrest Bigg Boss winner Elvish Yadav in snake venom case

Youtuber Elvish Yadav was arrested on Sunday by Noida Police in connection with a probe into the suspected use of snake venom as a recreational drug at a party here, officials said. Yadav was among six people named in an FIR lodged at Sector 49 police station here on November 3 last year. The five other accused were arrested but are currently out on bail, the officials said. The case was lodged under provisions of the Wildlife Protection Act, 1972 and for criminal conspiracy under section 120B of the Indian Penal Code, they said. The case was later shifted from Sector 49 to Sector 20 police station for investigation. "The accused has been arrested by a team of Sector 20 police station which was investigating the case," Additional DCP (Noida) Manish Mishra told PTI. Yadav, a winner of reality show Bigg Boss OTT, has refuted the charges of involvement in the case and has been questioned by the police in the past. A sub-inspector, who was also the incharge of the local Sector 49 pol

Panel formed to administer pricing reforms for drugs, medical devices

Centre constitutes Committee for reforms in pricing framework for drugs and medical devices

Govt revamps pharma scheme, to provide financial assistance to drug cos

Financial support for drug companies also comes against the backdrop of deaths being reported abroad due to the manufacture of substandard drugs linked to Indian companies